Atlas Trials

Kallyope Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kallyope Inc.

RecordFirmDate
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine (NCT07674654)Kallyope Inc.2026-08-03
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine (NCT07645924)Kallyope Inc.2026-07-01
A Study of K-645 in the Treatment of Multiple Migraine Attacks (NCT07116499)Kallyope Inc.2025-08-12
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine (NCT06848075)Kallyope Inc.2025-03-05
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes (NCT06305351)Kallyope Inc.2023-12-07
A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833 (NCT06019559)Kallyope Inc.2023-09-15
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes (NCT05890950)Kallyope Inc.2023-03-13
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers (NCT05900531)Kallyope Inc.2022-09-21

Track Kallyope Inc. automatically

Every clearance here is in the API, with alerts when new ones post.